Significant Merger Enhances Down Syndrome Advocacy and Research
The National Down Syndrome Society (NDSS) has made waves with its recent merger with the LuMind IDSC Foundation, a prominent establishment recognized for its work in Down syndrome and Alzheimer’s disease research. This merging of forces combines the extensive advocacy and outreach capabilities of NDSS with the targeted research expertise of LuMind, marking an exciting new chapter for the Down syndrome community.
A New Era for Research and Advocacy
Under the leadership of Kandi Pickard, who will continue as CEO of NDSS, this merger symbolizes a return to prioritizing research while simultaneously strengthening advocacy efforts. For nearly five decades, NDSS has stood as the voice for individuals with Down syndrome, pushing for necessary resources and support throughout their lives. Now, with the integration of LuMind, there lies a renewed focus on research that directly impacts health outcomes.
Pivotal Health Focus
One of the critical elements underscoring this merger is the alarming statistic relating to Alzheimer’s disease. Individuals with Down syndrome face a striking 90% lifetime risk of developing the disease, which often manifests at an earlier age and progresses more rapidly than in the general population. Pickard emphasizes the importance of equipping families with the resources, research knowledge, and access to clinical trials that can dramatically improve their loved ones' lives.
Expanding Research Capacities
The newly formed research pillar of NDSS will not only prioritize Alzheimer’s disease but also health equity campaigns. This expanded capacity allows for a greater focus on innovative programs like CARE Down Syndrome. The aim is to provide primary care providers with essential educational tools to address the unique healthcare needs of individuals with Down syndrome, ensuring they receive the appropriate attention crucial for their well-being.
Empowering Families Through Research
At the forefront of this initiative is Hampus Hillerstrom, the current CEO of LuMind, who will transition to serve as President of NDSS. Hillerstrom has voiced his enthusiasm regarding the merger, signaling that research will continue to thrive under NDSS’s umbrella. The collective vision is to not only advance scientific discoveries but also to translate those advances into tangible benefits for families dealing with Down syndrome.
A Personal Connection
This merger holds personal significance for NDSS Board Chairman Carlo Frappolli. Having a brother with Down syndrome who is currently battling Alzheimer’s disease, Frappolli's involvement brings an emotional weight to the mission. He articulates the urgency of harnessing this collaboration to foster better health outcomes for future generations.
Looking Ahead
As NDSS carries forward its existing programs and community initiatives, the addition of LuMind brings scientific momentum aimed at creating a future where individuals with Down syndrome are equipped with the necessary resources and support to navigate their lives successfully. With the merger effective from October 1, a series of public announcements and outreach activities will commence shortly, aiming to engage and inform families about the exciting developments ahead.
Frequently Asked Questions
What is the significance of the merger between NDSS and LuMind?
This merger combines NDSS's advocacy and outreach with LuMind's research expertise, enhancing support for individuals with Down syndrome and their families.
How will the merger impact research on Down syndrome and Alzheimer’s disease?
It will facilitate increased clinical research projects, education tools, and access to treatments, thus driving better health outcomes.
Will current NDSS programs continue after the merger?
Yes, all existing NDSS programs, advocacy initiatives, and community efforts will remain active and robust.
Who will lead NDSS after the merger?
Kandi Pickard will continue as the CEO, and Hampus Hillerstrom will become the President.
When is the merger effective?
The merger officially takes effect on October 1, with public outreach and announcements launching shortly thereafter.
